What Chemotherapy Drugs Are Used for Mesothelioma?

First-Line Chemotherapy Drugs

The gold standard chemotherapy regimen for malignant mesothelioma is the combination of pemetrexed (marketed as Alimta by Eli Lilly) with cisplatin. Pemetrexed is an antifolate drug that inhibits multiple enzymes involved in DNA synthesis, effectively disrupting the cancer cell’s ability to replicate. Cisplatin is a platinum-based compound that cross-links DNA strands, preventing cell division.

This combination was approved by the FDA in 2004 after a landmark phase III trial demonstrated a significant survival benefit. The study showed median survival of 12.1 months with the combination versus 9.3 months with cisplatin alone. Patients receiving pemetrexed-cisplatin also had higher response rates and better symptom control.

Carboplatin as an Alternative

Carboplatin is frequently substituted for cisplatin, particularly in patients who are older, have reduced kidney function, or cannot tolerate cisplatin’s more severe side effects such as nephrotoxicity and ototoxicity. Several studies have shown that pemetrexed-carboplatin produces similar response rates and survival outcomes to pemetrexed-cisplatin, with a generally more favorable side effect profile.

The choice between cisplatin and carboplatin is made by the treating oncologist based on patient-specific factors. Both regimens are considered acceptable first-line options by the National Comprehensive Cancer Network (NCCN) guidelines.

HIPEC Chemotherapy Agents

For peritoneal mesothelioma patients undergoing HIPEC surgery, chemotherapy drugs are heated to 41–43°C and delivered directly into the abdominal cavity after cytoreductive surgery. The most commonly used HIPEC agents are cisplatin alone, cisplatin combined with doxorubicin, and mitomycin C.

Heating the chemotherapy solution enhances drug penetration into tissue and increases cytotoxicity against remaining cancer cells. Direct intraperitoneal delivery allows for much higher drug concentrations at the tumor site than systemic administration, while reducing overall side effects.

Second-Line and Investigational Drugs

When mesothelioma progresses after first-line treatment, several options exist. Immunotherapy with nivolumab plus ipilimumab has emerged as an important option. Traditional second-line chemotherapy drugs include gemcitabine (alone or with a platinum agent), vinorelbine, and retreatment with pemetrexed if there was a prolonged interval since first-line therapy.

Clinical trials are actively investigating new agents and combinations. Patients interested in accessing investigational treatments should discuss options with their oncologist or contact a specialized mesothelioma treatment center with active clinical trial programs.

Supportive Medications

Patients receiving pemetrexed-based chemotherapy require supplementation with folic acid (taken daily) and vitamin B12 (injection every 9 weeks) starting at least one week before treatment. These supplements significantly reduce the risk of severe side effects. Dexamethasone is also given before each infusion to prevent skin rashes. Anti-nausea medications are routinely prescribed to manage chemotherapy-induced nausea and vomiting.

If you have been diagnosed with mesothelioma and are facing treatment costs, legal compensation may be available to help cover expenses related to your asbestos exposure.